Cargando…

Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa

BACKGROUND: Hepatitis C virus (HCV) infection is a major global public health problem in both developed and developing countries. The prevalence and genetic diversity of HCV in pregnant women in Gabon, central Africa, is not known. We therefore evaluated the prevalence and the circulating genotypes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndong-Atome, Guy-Roger, Makuwa, Maria, Njouom, Richard, Branger, Michel, Brun-Vézinet, Francoise, Mahé, Antoine, Rousset, Dominique, Kazanji, Mirdad
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442078/
https://www.ncbi.nlm.nih.gov/pubmed/18559087
http://dx.doi.org/10.1186/1471-2334-8-82
_version_ 1782156666585743360
author Ndong-Atome, Guy-Roger
Makuwa, Maria
Njouom, Richard
Branger, Michel
Brun-Vézinet, Francoise
Mahé, Antoine
Rousset, Dominique
Kazanji, Mirdad
author_facet Ndong-Atome, Guy-Roger
Makuwa, Maria
Njouom, Richard
Branger, Michel
Brun-Vézinet, Francoise
Mahé, Antoine
Rousset, Dominique
Kazanji, Mirdad
author_sort Ndong-Atome, Guy-Roger
collection PubMed
description BACKGROUND: Hepatitis C virus (HCV) infection is a major global public health problem in both developed and developing countries. The prevalence and genetic diversity of HCV in pregnant women in Gabon, central Africa, is not known. We therefore evaluated the prevalence and the circulating genotypes of HCV in a large population cohort of pregnant women. METHODS: Blood samples (947) were collected from pregnant women in the five main cities of the country. The prevalence was evaluated by two ELISA tests, and the circulating genotypes were characterized by sequencing and phylogenetic analysis. RESULTS: Twenty pregnant women (2.1%) were infected with HCV. The seroprevalence differed significantly by region (p = 0.004) and increased significantly with age (p = 0.05), being 1.3% at 14–20 years, 1.1% at 21–25 years, 1.9% at 26–30 years, 4.1% at 31–35 years and 6.0% at > 35 years. Sequencing in the 5'-UTR and NS5B regions showed that the circulating strains belonged to genotypes 4 (4e and 4c). CONCLUSION: We found that the HCV seroprevalence in pregnant women in Gabon is almost as high as that in other African countries and increases with age. Furthermore, only genotype 4 (4e and 4c) was found. More extensive studies aiming to evaluate the prevalence and heterogeneity of HCV genotypes circulating in the general population of the country are needed.
format Text
id pubmed-2442078
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24420782008-07-01 Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa Ndong-Atome, Guy-Roger Makuwa, Maria Njouom, Richard Branger, Michel Brun-Vézinet, Francoise Mahé, Antoine Rousset, Dominique Kazanji, Mirdad BMC Infect Dis Research Article BACKGROUND: Hepatitis C virus (HCV) infection is a major global public health problem in both developed and developing countries. The prevalence and genetic diversity of HCV in pregnant women in Gabon, central Africa, is not known. We therefore evaluated the prevalence and the circulating genotypes of HCV in a large population cohort of pregnant women. METHODS: Blood samples (947) were collected from pregnant women in the five main cities of the country. The prevalence was evaluated by two ELISA tests, and the circulating genotypes were characterized by sequencing and phylogenetic analysis. RESULTS: Twenty pregnant women (2.1%) were infected with HCV. The seroprevalence differed significantly by region (p = 0.004) and increased significantly with age (p = 0.05), being 1.3% at 14–20 years, 1.1% at 21–25 years, 1.9% at 26–30 years, 4.1% at 31–35 years and 6.0% at > 35 years. Sequencing in the 5'-UTR and NS5B regions showed that the circulating strains belonged to genotypes 4 (4e and 4c). CONCLUSION: We found that the HCV seroprevalence in pregnant women in Gabon is almost as high as that in other African countries and increases with age. Furthermore, only genotype 4 (4e and 4c) was found. More extensive studies aiming to evaluate the prevalence and heterogeneity of HCV genotypes circulating in the general population of the country are needed. BioMed Central 2008-06-17 /pmc/articles/PMC2442078/ /pubmed/18559087 http://dx.doi.org/10.1186/1471-2334-8-82 Text en Copyright © 2008 Atome et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ndong-Atome, Guy-Roger
Makuwa, Maria
Njouom, Richard
Branger, Michel
Brun-Vézinet, Francoise
Mahé, Antoine
Rousset, Dominique
Kazanji, Mirdad
Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa
title Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa
title_full Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa
title_fullStr Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa
title_full_unstemmed Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa
title_short Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa
title_sort hepatitis c virus prevalence and genetic diversity among pregnant women in gabon, central africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442078/
https://www.ncbi.nlm.nih.gov/pubmed/18559087
http://dx.doi.org/10.1186/1471-2334-8-82
work_keys_str_mv AT ndongatomeguyroger hepatitiscvirusprevalenceandgeneticdiversityamongpregnantwomeningaboncentralafrica
AT makuwamaria hepatitiscvirusprevalenceandgeneticdiversityamongpregnantwomeningaboncentralafrica
AT njouomrichard hepatitiscvirusprevalenceandgeneticdiversityamongpregnantwomeningaboncentralafrica
AT brangermichel hepatitiscvirusprevalenceandgeneticdiversityamongpregnantwomeningaboncentralafrica
AT brunvezinetfrancoise hepatitiscvirusprevalenceandgeneticdiversityamongpregnantwomeningaboncentralafrica
AT maheantoine hepatitiscvirusprevalenceandgeneticdiversityamongpregnantwomeningaboncentralafrica
AT roussetdominique hepatitiscvirusprevalenceandgeneticdiversityamongpregnantwomeningaboncentralafrica
AT kazanjimirdad hepatitiscvirusprevalenceandgeneticdiversityamongpregnantwomeningaboncentralafrica